ACHE and hepatocellular carcinoma: It has been demonstrated that (AChE) was significantly downregulated in the cancerous tissues of 69.2% of HCC patients, and low (AChE) expression in HCC was correlated with tumor aggressiveness, an elevated risk of postoperative recurrence, and a low survival rate.